Literature DB >> 25216863

Association between Toll-like receptor 4 and interleukin 17 gene polymorphisms and colorectal cancer susceptibility in Northeast China.

Lin Zhu1, Yibaina Wang, Ge Jie, Qiang Chi, Junde Zhou, Binbin Cui, Daxun Piao, Yashuang Zhao.   

Abstract

Limited studies about the effects of TLR 4 and IL17 polymorphisms (SNPs) on the risk of colorectal cancer (CRC) have yielded inconsistent results. Totally, 601 CRC patients and 627 controls were enrolled. Unconditional logistic regression was used to estimate the association between tagSNPs and susceptibility of CRC and the interactions effects of gene and environment on the risk of CRC. IL17 rs6973569 AG and AG/AA genotypes significantly decreased the risk of CRC compared with GG genotype (ORadjusted=0.72, 95% CI 0.55-0.94 and ORadjusted=0.74, 95 % CI 0.57-0.97). The haplotype G-T-G-C-A-G accounting for the largest proportion haplotypes increased the risk of CRC (OR=1.27, 95 % CI 1.06-1.53). However, G-C-C-T-A-G and G-C-G-C-A-G haplotypes decreased the susceptibility of CRC. Synergistic interactions between TLR 4 rs1927911 CT/TT and higher pungent food intake as well as IL17 rs6973569 AG/AA genotypes and higher intake of sausage food (ORi=1.72, 95% CI 1.04-2.84 and ORi=3.38, 95% CI 1.28-8.91) on the risk of CRC were observed. IL17 rs6973569 SNP might be an independent factor of susceptibility to CRC. TLR 4 haplotype of G-T-G-C-A-G may increase risk of CRC. Higher intake of pungent and sausage food synergistically interacted with TLR 4 and IL17 SNPs on the risk of CRC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25216863     DOI: 10.1007/s12032-014-0073-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  39 in total

Review 1.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 2.  T(H)17 cells in tumour immunity and immunotherapy.

Authors:  Weiping Zou; Nicholas P Restifo
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

Review 3.  TLR4 signalling in the intestine in health and disease.

Authors:  M Fukata; M T Abreu
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

4.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

5.  Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.

Authors:  Masayuki Fukata; Anli Chen; Arielle Klepper; Suneeta Krishnareddy; Arunan S Vamadevan; Lisa S Thomas; Ruliang Xu; Hiroyasu Inoue; Moshe Arditi; Andrew J Dannenberg; Maria T Abreu
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

6.  Genetic epistasis of IL23/IL17 pathway genes in Crohn's disease.

Authors:  Dermot P B McGovern; Jerome I Rotter; Ling Mei; Talin Haritunians; Carol Landers; Carrie Derkowski; Deb Dutridge; Marla Dubinsky; Andy Ippoliti; Eric Vasiliauskas; Emebet Mengesha; Lily King; Sheila Pressman; Stephan R Targan; Kent D Taylor
Journal:  Inflamm Bowel Dis       Date:  2009-06       Impact factor: 5.325

Review 7.  Interleukin-17 family members and inflammation.

Authors:  Jay K Kolls; Anders Lindén
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

8.  Inhibition of cell growth and induction of apoptosis via inactivation of NF-kappaB by a sulfurcompound isolated from garlic in human colon cancer cells.

Authors:  Jung Ok Ban; Dong Yeon Yuk; Koan Sik Woo; Tae Myoung Kim; Ung Soo Lee; Heon-Sang Jeong; Dae Joong Kim; Yeun Bok Chung; Bang Yeon Hwang; Ki Wan Oh; Jin Tae Hong
Journal:  J Pharmacol Sci       Date:  2007-08       Impact factor: 3.337

9.  Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.

Authors:  Ming-Hsi Wang; Kathy J Helzlsouer; Michael W Smith; Judith A Hoffman-Bolton; Sandra L Clipp; Viktoriya Grinberg; Angelo M De Marzo; William B Isaacs; Charles G Drake; Yin Yao Shugart; Elizabeth A Platz
Journal:  Prostate       Date:  2009-06-01       Impact factor: 4.104

10.  Association analysis of IL-17A and IL-17F polymorphisms in Chinese Han women with breast cancer.

Authors:  Lihong Wang; Yongdong Jiang; Youxue Zhang; Yuwen Wang; Sunhui Huang; Zhihua Wang; Baoling Tian; Yue Yang; Wei Jiang; Da Pang
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

View more
  5 in total

1.  Interleukin-17A polymorphisms predict the response and development of tolerance to FOLFOX chemotherapy in colorectal cancer treatment.

Authors:  Sinda Bedoui; Meriem Dallel; Mouadh Barbirou; Mouna Stayoussef; Amina Mokrani; Amel Mezlini; Balkiss Bouhaouala; Wassim Y Almawi; Besma Yacoubi-Loueslati
Journal:  Cancer Gene Ther       Date:  2019-05-29       Impact factor: 5.987

2.  Interleukin-17A and interleukin-17F gene polymorphisms and hepatitis B virus-related hepatocellular carcinoma risk in a Chinese population.

Authors:  Xue-E Xi; Yanqiong Liu; Yu Lu; Liying Huang; Xue Qin; Shan Li
Journal:  Med Oncol       Date:  2014-11-28       Impact factor: 3.064

3.  Network Pharmacology-Based Study on the Mechanism of Gegen Qinlian Decoction against Colorectal Cancer.

Authors:  Qiaowei Fan; Lin Guo; Jingming Guan; Jing Chen; Yujing Fan; Zhendong Chen; Hulun Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-26       Impact factor: 2.629

4.  Comprehensive assessment of association between TLR4 gene polymorphisms and cancer risk: a systematic meta-analysis.

Authors:  Lu Ding; Qifeng Jiang; Guang Li; Jia Shen; Jiayin Du; Xiaochen Lu; Xingliang Xiong
Journal:  Oncotarget       Date:  2017-10-06

5.  Polymorphisms in GEMIN4 and AGO1 Genes Are Associated with the Risk of Lung Cancer: A Case-Control Study in Chinese Female Non-Smokers.

Authors:  Xue Fang; Zhihua Yin; Xuelian Li; Lingzi Xia; Baosen Zhou
Journal:  Int J Environ Res Public Health       Date:  2016-09-23       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.